Wednesday, July 8, 2026

pharma · Type 2 Diabetes Mellitus · Irritable Bowel Syndrome · LXRX

LEXICON PHARMACEUTICALS

Lexicon Pharmaceuticals is a pharma organization headquartered in The Woodlands, USA. It trades on NYSE under ticker LXRX. Primary therapeutic focus areas include Type 2 Diabetes Mellitus, Irritable Bowel Syndrome, Rheum

8800 Technology Forest, The Woodlands, TX 77381, US HQ
1995 Founded
282 Employees
Public company Type
LXRX · NYSE Ticker
Company details
Status
Public
HQ
8800 Technology Forest, The Woodlands, TX 77381, US
Founded
1995
Employees
282
Programs
51
Drugs
27
Patents
102
Clinical program

LX4211 400 mg

Phase 1 · small molecule · Healthy

LX4211 400 mg for Healthy is a Phase 1 program (small_molecule) at LEXICON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

← All LEXICON PHARMACEUTICALS, INC. projects Phase 1 small molecule completed

Internal code LX4211.1-110-NRM

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
LEXICON PHARMACEUTICALS, INC.
Phase
Phase 1
Modality
small_molecule
Indication
Healthy
Status
completed
Trials
1

Clinical trials